17219201 |
Molecular genetic defects in endometrial carcinomas: microsatellite instability, PTEN and beta-catenin (CTNNB1) genes mutations
Olszewski, W,
Paszko, Z,
Janiec-Jankowska, A,
BidziĆski, M,
Czapczak, D,
Konopka, B,
Goluda, C
|
J. Cancer Res. Clin. Oncol. |
2007 |
10866302 |
Functional evaluation of PTEN missense mutations using in vitro phosphoinositide phosphatase assay
Kato, H,
Shibata, H,
Matsuno, S,
Shiiba, K,
Han, SY,
Kato, S,
Ishioka, C,
Ishii, S,
Kanamaru, R,
Suzuki, T
|
Cancer Res |
2000 |
10555148 |
Crystal structure of the PTEN tumor suppressor: implications for its phosphoinositide phosphatase activity and membrane association
Georgescu, MM,
Pavletich, NP,
Shi, Y,
Maehama, T,
Pandolfi, P,
Yang, H,
Lee, JO,
Dixon, JE,
Di Cristofano, A
|
Cell |
1999 |
9326929 |
PTEN1 is frequently mutated in primary endometrial carcinomas
Zou, TT,
Abraham, JM,
Kong, D,
Horii, A,
Yamakawa, H,
Suzuki, A,
Yokoyama, T,
Sato, M,
Sakurada, A,
Furukawa, T,
Wang, S,
Souza, RF,
Sato, S,
Smolinski, KN,
Ohuchi, N,
Yin, J,
Meltzer, SJ,
Kemp, LW,
Wakatsuki, S
|
Nat. Genet. |
1997 |
11948419 |
Motif analysis of the tumor suppressor gene MMAC/PTEN identifies tyrosines critical for tumor suppression and lipid phosphatase activity
Yung, WK,
Shi, Y,
Jasser, SA,
Davies, MA,
Lu, Y,
Koul, D,
Mills, GB,
Shen, R
|
Oncogene |
2002 |